Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Non-Muscle Invasive Bladder Neoplasms × Neoadjuvant Therapy × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 9 Neoplasms 3 Triple Negative Breast Neoplasms 2 Rectal Neoplasms 2 Lung Neoplasms 2 Squamous Cell Carcinoma of External Auditory Canal 1 Sarcoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Ovarian Neoplasms 1 Neoplasm, Residual 1 Multiple Myeloma 1 Microsatellite Instability 1 Melanoma 1 Medulloblastoma 1 Liposarcoma 1 Leiomyosarcoma 1 High-Risk Cancer 1 Esophageal Squamous Cell Carcinoma 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Intraductal, Noninfiltrating 1 Carcinoma, Hepatocellular 1 Breast Neoplasms, Male 1

Interventions

Gemcitabine 8 Mitomycin 5 erdafitinib 4 dodecyl maltoside 4 Cystoscopy 3 Docetaxel 2 BCG Vaccine 2 pirarubicin 1 hydroxycamptothecinum 1 Transurethral Resection of Bladder 1 Patient Discharge 1 Paclitaxel 1 Magnetic Resonance Spectroscopy 1 Injections 1 Imiquimod 1 Epirubicin 1 Drainage 1 Clinical Trials, Phase II as Topic 1 Clinical Trials, Phase I as Topic 1 Accelerometry 1 5-aminolevulinic acid hexyl ester 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡